AMARZGUIOUIM.et al.2006. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat. Protoc., 1:508–517.
2.
CALING.A.et al.2002. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A., 99:15524–15529.
3.
CAPLENN.J., PARRISHS., IMANIF., FIREA., MORGANR.A.S.2001. pecific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. U. S. A., 98:9742–9747.
4.
DAVISM.E.et al.2010. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464:1067–1070.
5.
DIGIUSTOD.L.et al.2010. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci. Transl. Med., 2:36ra43.
6.
ELBASHIRS.M.et al.2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411:494–498.
7.
FIREA.et al.1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391:806–811.
8.
GRIMMD.et al.2006. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441:537–541.
9.
KLEINMANM.E.et al.2008. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature, 452:591–597.
10.
LEER.C., FEINBAUMR.L., AMBROSV.1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75:843–854.
11.
NEFFC.P.et al.2011. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4+ T Cell decline in humanized mice. Sci. Transl. Med., 3:66ra66.
